Xtx Topco LTD Aveo Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.15 - $6.01 $57,103 - $108,949	-18,128 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.69 - $7.4 $85,020 - $134,147	18,128 New	18,128 $85,000
Q2 2021 Aug 12, 2021	SELL	$6.21 - $7.45 $94,963 - $113,925	-15,292 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.97 - $15.28 $91,293 - $233,661	15,292 New	15,292 $112,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.